Fig. 1: Decreased leukocyte N6-methyladenosine (m6A) DNA level is associated with carotid plaque progression in patients with atherosclerosis (AS). | Cell Death & Disease

Fig. 1: Decreased leukocyte N6-methyladenosine (m6A) DNA level is associated with carotid plaque progression in patients with atherosclerosis (AS).

From: Association of N6-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts

Fig. 1

a Leukocyte m6A level in AS patients and normal individuals (N). Data are mean ± SD and were compared by unpaired t test. b–d Spearman correlation coefficients for leukocyte m6A level correlated with age (b), carotid plaque size (c), and carotid intima media thickness (CIMT) (d). Overall carotid plaque size (e) and CIMT (f) by leukocyte m6A level. Data are mean ± SD and were compared by one-way ANOVA, followed by Bonferroni’s multiple comparison test. *P < 0.05, **P < 0.01, ***P < 0.001. ns not significant.

Back to article page